Skip to main content
Fig. 5 | Renal Replacement Therapy

Fig. 5

From: Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients

Fig. 5

Percentage of patients within PTH control targets before and after switching from cinacalcet to evocalcet. Purple columns represent patients with i-PTH within target values under cinacalcet treatment, while blue ones represent those with i-PTH within target values under evocalcet treatment. Yellow columns represent patients with i-PTH < 60 pg/mL, while orange ones represent those with i-PTH > 240 pg/mL. i-PTH intact parathyroid hormone, BL baseline

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us